🇺🇸 FDA
Patent

US 8784870

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

granted A61KA61K31/05A61K31/135

Quick answer

US patent 8784870 (Controlled release compositions for modulating free-radical induced damage and methods of use thereof) held by The Regents of the University of California expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/05, A61K31/135, A61K31/498, A61K38/05